American Bio Medica
This article was originally published in The Gray Sheet
Oxycodone Rapid One OXY point-of-care assay for detecting abuse of the drug gains 510(k) clearance. Results derived from a urine sample can be ascertained within minutes to detect even "a very low level" of oxycodone, ABM claims. The test is the first on-site assay for the drug to be approved by FDA...
You may also be interested in...
New guidance from the UK regulator covers distribution and deployment of Pfizer/BioNTech's COVID-19 vaccine, which will be complex because of the temperature storage requirements and the large packs in which the vaccine doses will be delivered.
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.
Alpha Source hired a new CEO from Mayline, while Mölnlycke’s CEO comes from CellaVision; Xvivo Perfusion finance chief changed job to become chief operating officer; Shire senior VP now COO at AVITA; and more.